EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glucose alters the evolutionary response to gentamicin in uropathogenic Escherichia coli

Shalini Choudhary, Jacob A Smith, Alan McNally, Rebecca J Hall

Microbiology · 2025

DOI: 10.1099/mic.0.001548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology, 2025. Verfasst von Shalini Choudhary und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbes, Infection and Microbiomes, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Bi…. Hauptthemen laut MEDLINE: Uropathogenic Escherichia coli, Glucose, Gentamicins, Anti-Bacterial Agents. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urinary tract infections (UTI) are a major health and economic concern. Uropathogenic Escherichia coli (UPEC) are the leading cause of UTI, and antibiotic-resistant UPEC are increasingly common. The microenvironment of the urinary tract is metabolically distinct, and there is growing interest in understanding the extent to which metabolism may influence UPEC infection and response to antibiotics, and how this varies between individuals. Diabetes, characterized in part by glycosuria, is a known risk factor for UTI and is associated with more severe infections. The role that glucose plays in driving UPEC evolution remains unclear. Through experimental evolution with a single UPEC isolate, we identified mutations in the RNA polymerase sigma factor rpoS associated with long-term glucose exposure. We found that the presence of the antibiotic gentamicin resulted in mutations in genes including trkH , which encodes a potassium ion uptake system previously linked to aminoglycoside resistance, and in the autotransporter hyxB . Strikingly, these mutations were not present in populations exposed to a combination of both glucose and gentamicin. This suggests that glucose may influence the survival of mutants in gentamicin, providing new avenues for understanding the evolution and treatment of UPEC-mediated UTI in high-risk individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uropathogenic Escherichia coliGlucoseGentamicinsAnti-Bacterial AgentsUrinary Tract InfectionsEscherichia coli ProteinsSigma FactorBacterial ProteinsMutationHumansEscherichia coli InfectionsDrug Resistance, Bacterial

Stichwörter der Autor:innen

antimicrobial resistancegentamicinglucoseuropathogenic Escherichia coli

Substanzen

GlucoseGentamicinsAnti-Bacterial AgentsEscherichia coli ProteinsSigma FactorBacterial Proteinssigma factor KatF protein, Bacteria

Autor:innen und Institutionen

  • Department of Microbes, Infection and Microbiomes, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, B15 2TT, UK.

Förderung

  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Choudhary, S., Smith, J. A., McNally, A., & Hall, R. J. (2025). Glucose alters the evolutionary response to gentamicin in uropathogenic Escherichia coli. Microbiology. https://doi.org/10.1099/mic.0.001548

Vancouver

Choudhary S, Smith JA, McNally A, Hall RJ. Glucose alters the evolutionary response to gentamicin in uropathogenic Escherichia coli. Microbiology. 2025. doi:10.1099/mic.0.001548

BibTeX
@article{Choudhary2025,
  author = {Choudhary, Shalini and Smith, Jacob A and McNally, Alan and Hall, Rebecca J},
  title = {Glucose alters the evolutionary response to gentamicin in uropathogenic Escherichia coli},
  journal = {Microbiology},
  year = {2025},
  doi = {10.1099/mic.0.001548}
}
Kostenlos starten →